These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 36858636)

  • 21. Diagnostic utility of metabolic parameters on FDG PET/CT for lymph node metastasis in patients with cN2 non-small cell lung cancer.
    Nakanishi K; Nakamura S; Sugiyama T; Kadomatsu Y; Ueno H; Goto M; Ozeki N; Fukui T; Iwano S; Chen-Yoshikawa TF
    BMC Cancer; 2021 Sep; 21(1):983. PubMed ID: 34474680
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development and Validation of a Preoperative Magnetic Resonance Imaging Radiomics-Based Signature to Predict Axillary Lymph Node Metastasis and Disease-Free Survival in Patients With Early-Stage Breast Cancer.
    Yu Y; Tan Y; Xie C; Hu Q; Ouyang J; Chen Y; Gu Y; Li A; Lu N; He Z; Yang Y; Chen K; Ma J; Li C; Ma M; Li X; Zhang R; Zhong H; Ou Q; Zhang Y; He Y; Li G; Wu Z; Su F; Song E; Yao H
    JAMA Netw Open; 2020 Dec; 3(12):e2028086. PubMed ID: 33289845
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diagnostic value of a radiomics model based on CT and MRI for prediction of lateral lymph node metastasis of rectal cancer.
    Yang H; Jiang P; Dong L; Li P; Sun Y; Zhu S
    Updates Surg; 2023 Dec; 75(8):2225-2234. PubMed ID: 37556079
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Breast imaging. Preoperative breast cancer staging: comparison of USPIO-enhanced MR imaging and 18F-fluorodeoxyglucose (FDC) positron emission tomography (PET) imaging for axillary lymph node staging--initial findings.
    Stadnik TW; Everaert H; Makkat S; Sacré R; Lamote J; Bourgain C
    Eur Radiol; 2006 Oct; 16(10):2153-60. PubMed ID: 16670863
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diagnostic Performance of Dedicated Axillary T2- and Diffusion-weighted MR Imaging for Nodal Staging in Breast Cancer.
    Schipper RJ; Paiman ML; Beets-Tan RG; Nelemans PJ; de Vries B; Heuts EM; van de Vijver KK; Keymeulen KB; Brans B; Smidt ML; Lobbes MB
    Radiology; 2015 May; 275(2):345-55. PubMed ID: 25513854
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predicting lymph node metastasis in pancreatobiliary cancer with magnetic resonance imaging: A prospective analysis.
    Lee JH; Han SS; Hong EK; Cho HJ; Joo J; Park EY; Woo SM; Kim TH; Lee WJ; Park SJ
    Eur J Radiol; 2019 Jul; 116():1-7. PubMed ID: 31153550
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Usefulness of preoperative breast magnetic resonance imaging with a dedicated axillary sequence for the detection of axillary lymph node metastasis in patients with early ductal breast cancer.
    Ahn HS; Jang M; Kim SM; La Yun B; Lee SH
    Radiol Med; 2019 Dec; 124(12):1220-1228. PubMed ID: 31422573
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preoperative assessment of lymph node metastasis in Colon Cancer patients using machine learning: a pilot study.
    Eresen A; Li Y; Yang J; Shangguan J; Velichko Y; Yaghmai V; Benson AB; Zhang Z
    Cancer Imaging; 2020 Apr; 20(1):30. PubMed ID: 32334635
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Peritumoral edema enhances MRI-based deep learning radiomic model for axillary lymph node metastasis burden prediction in breast cancer.
    Luo H; Chen Z; Xu H; Ren J; Zhou P
    Sci Rep; 2024 Aug; 14(1):18900. PubMed ID: 39143315
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diagnostic performance of standard breast MRI compared to dedicated axillary MRI for assessment of node-negative and node-positive breast cancer.
    Samiei S; Smidt ML; Vanwetswinkel S; Engelen SME; Schipper RJ; Lobbes MBI; van Nijnatten TJA
    Eur Radiol; 2020 Aug; 30(8):4212-4222. PubMed ID: 32221685
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Machine learning-based MRI texture analysis to predict occult lymph node metastasis in early-stage oral tongue squamous cell carcinoma.
    Yuan Y; Ren J; Tao X
    Eur Radiol; 2021 Sep; 31(9):6429-6437. PubMed ID: 33569617
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lymph Node Metastasis Prediction from Primary Breast Cancer US Images Using Deep Learning.
    Zhou LQ; Wu XL; Huang SY; Wu GG; Ye HR; Wei Q; Bao LY; Deng YB; Li XR; Cui XW; Dietrich CF
    Radiology; 2020 Jan; 294(1):19-28. PubMed ID: 31746687
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Positive predictive value of axillary lymph node cortical thickness and nodal, clinical, and tumor characteristics in newly diagnosed breast cancer patients.
    Loonis AT; Chesebro AL; Bay CP; Portnow LH; Weiss A; Chikarmane SA; Giess CS
    Breast Cancer Res Treat; 2024 Feb; 203(3):511-521. PubMed ID: 37950089
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predicting Axillary Response to Neoadjuvant Chemotherapy: Breast MRI and US in Patients with Node-Positive Breast Cancer.
    Kim R; Chang JM; Lee HB; Lee SH; Kim SY; Kim ES; Cho N; Moon WK
    Radiology; 2019 Oct; 293(1):49-57. PubMed ID: 31407967
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adding contrast-enhanced ultrasound markers to conventional axillary ultrasound improves specificity for predicting axillary lymph node metastasis in patients with breast cancer.
    Du LW; Liu HL; Gong HY; Ling LJ; Wang S; Li CY; Zong M
    Br J Radiol; 2021 Feb; 94(1118):20200874. PubMed ID: 32976019
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of the diagnostic performance of apparent diffusion coefficient (ADC) values on diffusion-weighted magnetic resonance imaging (DWI) in differentiating between benign and metastatic lymph nodes in cases of cholangiocarcinoma.
    Promsorn J; Soontrapa W; Somsap K; Chamadol N; Limpawattana P; Harisinghani M
    Abdom Radiol (NY); 2019 Feb; 44(2):473-481. PubMed ID: 30151713
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Does ultrasound evaluation of the axilla increase the rate of axillary lymph node dissection in early stage clinically node negative breast cancer patients?
    Vasigh M; Meshkati Yazd SM; Karoobi M; Hajebi R; Yazdankhah Kenari A
    BMC Surg; 2022 Mar; 22(1):80. PubMed ID: 35241059
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prediction of axillary response by monitoring with ultrasound and MRI during and after neoadjuvant chemotherapy in breast cancer patients.
    Eun NL; Son EJ; Gweon HM; Kim JA; Youk JH
    Eur Radiol; 2020 Mar; 30(3):1460-1469. PubMed ID: 31802216
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predicting axillary lymph node metastasis in breast cancer using the similarity of quantitative dual-energy CT parameters between the primary lesion and axillary lymph node.
    Terada K; Kawashima H; Yoneda N; Toshima F; Hirata M; Kobayashi S; Gabata T
    Jpn J Radiol; 2022 Dec; 40(12):1272-1281. PubMed ID: 35877033
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diagnostic performance of T2-weighted imaging and intravoxel incoherent motion diffusion-weighted MRI for predicting metastatic axillary lymph nodes in T1 and T2 stage breast cancer.
    Liu Y; Luo H; Wang C; Chen X; Wang M; Zhou P; Ren J
    Acta Radiol; 2022 Apr; 63(4):447-457. PubMed ID: 33779304
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.